Then, analyses stratified by different country showed a significant association of elevated prostate cancer risk with GSTM1 deletion in China and Korea, the ORs were 1.665 (95%CI = 1.324 – 2.094) and 1.914 (95%CI = 1.311 – 2.793) respectively. This evidence concerns the gene GSTM1 and prostate cancer.